Filing Details
- Accession Number:
- 0001140361-24-035583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-02 18:08:23
- Reporting Period:
- 2024-07-31
- Accepted Time:
- 2024-08-02 18:08:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9326 | Balchem Corp | BCPC | Chemicals & Allied Products (2800) | 132578432 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1906287 | Leonard Job Gunsteren Van | C/O Balchem Corp 5 Paragon Drive Montvale NJ 07645 | Svp And Gm, Specialty Products | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-31 | 4,000 | $58.52 | 12,540 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-07-31 | 3,750 | $60.85 | 16,290 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-31 | 7,750 | $180.05 | 8,540 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2024-07-31 | 4,000 | $0.00 | 4,000 | $58.52 |
Common Stock | Stock Options (right to buy) | Disposition | 2024-07-31 | 3,750 | $0.00 | 3,750 | $60.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-02-19 | No | 4 | M | Direct | |
0 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- Exercise of fully vested non-qualified stock options.
- This transaction was executed in multiple sales ranging from $180.0000 to $180.5300 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote
- Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable.
- Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.